
New member appointed to Roche board of directors
pharmafile | December 9, 2015 | Appointment | Business Services | Roche
The Roche board of directors has proposed Dr Claudia Süssmuth Dyckerhoff, currently senior partner at McKinsey & Company, for election to the board.
The appointment will become effective at the next annual general meeting on 1 March 2016.
Professor Dr Beatrice Weder di Mauro, a member of the board of directors since 2006, has decided to not stand for re-election at the AGM in 2016 following 10 years of tenure.
Christoph Franz, chairman of Roche says: “As a member of the Board and the Audit Committee, Beatrice Weder di Mauro has made significant contributions to Roche’s success with her broad expertise in economics. On behalf of the Roche board of directors, I would like to extend our sincerest thanks to her.”
He added: “I am delighted with our nomination of Claudia Süssmuth Dyckerhoff for election as a new member of the Board. She is a leader with extensive international experience in strategic consultancy in the healthcare industry, especially in Asian growth markets.”
As announced in May 2015, Julie Brown will also be nominated for election at the AGM in 2016. She is replacing Dame DeAnne Julius, who has decided to not stand for re-election.
Related Content

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

Roche candidate shows early promise for treating haemophilia A
Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

Roche advances treatment for Parkinson’s disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, …






